Bloodstream infections due to Candida species.
作者： J.R. Greig , A.L. Brown
DOI: 10.1016/J.JHIN.2003.12.008
关键词:
摘要:
elsevier.com
sci-hub.se 参考文章(3)
C.C Kibbler, S Seaton, R.A Barnes, W.R Gransden, R.E Holliman, E.M Johnson, J.D Perry, D.J Sullivan, J.A Wilson, Management and outcome of bloodstream infections due to Candida species in England and Wales. Journal of Hospital Infection. ,vol. 54, pp. 18- 24 ,(2003) , 10.1016/S0195-6701(03)00085-9
J. H. Rex, M. A. Pfaller, J. N. Galgiani, M. S. Bartlett, A. Espinel-Ingroff, M. A. Ghannoum, M. Lancaster, F. C. Odds, M. G. Rinaldi, T. J. Walsh, A. L. Barry, , Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections Clinical Infectious Diseases. ,vol. 24, pp. 235- 249 ,(1997) , 10.1093/CLINIDS/24.2.235
M. A. Pfaller, D. J. Diekema, Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility. Journal of Clinical Microbiology. ,vol. 40, pp. 3551- 3557 ,(2002) , 10.1128/JCM.40.10.3551-3557.2002